Posts Categorized: blog

Bakers Square Pie Card – holiday fundraiser!

Bakers Square Sweet Returns™ cards – $18 each This season help those who struggle with myasthenia gravis – and enjoy mouthwatering holiday pies at the same time!   When you purchase Bakers Square Sweet Returns™ cards for $18 apiece, a portion of your contribution goes toward Conquer MG’s effort to provide vital MG information to 2,000… Read more »

MG Research Gets NIH Funding Boost

Conquer MG is excited to share news that the National Institutes of Health (NIH) has awarded a team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. Conquer MG will join scientists and physicians from academic institutions, other patient advocacy groups, and biotech/pharma companies, to better understand… Read more »

Mindful Breathing – Simple but Powerful

by Julie Rowin, MD Modern science is catching up to the ancient wisdom of mindfulness and movement-based practices such as Meditation, Yoga, Breathing, Tai Chi and Qigong. These ancient techniques have plentiful scientific evidence backing beneficial effects as far reaching as improved psychological health, immune function, hormone balance and cognitive function. The Science Stress elevates… Read more »

Oct 27 Seminar – Clinical Trials and MG

  Sunday, October 27, 2019 FALL PATIENT SEMINAR “Myasthenia Gravis and Clinical Trials”  Rabia Malik, MD, Rush University Medical Center Angela Pontius, Ra Pharmaceuticals Palos Hospital Auditorium 12251 S. 80th Avenue, Palos Heights, IL Parking: Visitor Garage 2, Opposite Main Entrance (Click here)          “Prednisone has too many side effects. My MG… Read more »

IVIg, Plasma Exchange, and Emerging MG Treatments

On April 28, 2019, neurologist Ryan Jacobson, MD, Rush University Medical Center, spoke to 55 myasthenia gravis patients and friends at Conquer MG’s Spring Patient Seminar at Elmhurst Memorial Hospital in Illinois. Dr. Jacobson compared several important MG treatments: IVIg, plasma exchange, and emerging therapies rituximab and eculizumab (Soliris®). Presentation highlights are below. Click to… Read more »